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The carboxyl-terminal Src kinase (Csk) is an indispen-
sable negative regulator for the Src family tyrosine ki-
nases (SFKs) that play pivotal roles in various cell
signalings. To understand the molecular basis of the
Csk-mediated regulation of SFKs, we elucidated the
crystal structure of full-length Csk. The Csk crystal con-
sists of six molecules classified as active or inactive
states according to the coordinations of catalytic resi-
dues. Csk assembles the SH2 and SH3 domains differ-
ently from inactive SFKs, and their binding pockets are
oriented outward enabling the intermolecular interac-
tion. In active molecules, the SH2-kinase and SH2-SH3
linkers are tightly stuck to the N-lobe of the kinase do-
main to stabilize the active conformation, and there is a
direct linkage between the SH2 and the kinase domains.
In inactive molecules, the SH2 domains are rotated de-
stroying the linkage to the kinase domain. Cross-corre-
lation matrices for the active molecules reveal that the
SH2 domain and the N-lobe of the kinase domain move
as a unit. These observations suggest that Csk can be
regulated through coupling of the SH2 and kinase do-
mains and that Csk provides a novel built-in activation
mechanism for cytoplasmic tyrosine kinases.
The Src family tyrosine kinases (SFKs),1 benign relatives of
the oncogenic v-src gene product, are non-receptor types of
protein tyrosine kinases (PTKs) that are associated with the
plasma membrane through their fatty acylated N termini (1).
The SFKs serve as molecular switches involved in the initiation
of a variety of cellular events in the multicellular animals,
including cell growth and division, cell attachment and move-
ment, differentiation, survival, and death (2). The SFKs are
ordinarily present in an inactive state in which the phospho-
rylated C-terminal regulatory tyrosine binds to its own SH2
domain (3). In response to an external stimulus, an SFK be-
comes activated through dephosphorylation of the C-terminal
tyrosine or through binding to another protein that displaces
the intramolecular interaction. The phosphorylation of the reg-
ulatory tyrosine of SFK is strictly controlled by another PTK,
the C-terminal Src kinase (Csk) (4, 5). The loss-of-function of
Csk leads to constitutive activation of SFKs, accompanied by
severe defects in embryonic development (5). In contrast, gain-
of-function of Csk can readily down-regulate SFK-mediated cell
signaling (6). Therefore, to understand the function and regu-
lation of SFKs, it is essential to clarify the regulation mecha-
nism controlling the phosphorylation of the critical C-terminal
tyrosine.
Csk is a cytoplasmic PTK consisting of an SH3, an SH2, and
a kinase domain (4). Because it lacks an N-terminal acylation
signal, an autophosphorylation site, and a C-terminal regula-
tory tyrosine, all of which are conserved among SFKs, the
regulatory mechanism of Csk appears to be quite different from
those of SFKs. The molecular basis of Csk regulation has so far
been studied using mutated molecules and isolated domains (7,
8). However, lack of the entire structure of Csk has hampered
the evaluation of their physiological roles. Some evidence sug-
gests that the SH2 and/or SH3 domain of Csk is essential for
SFK regulation (7, 9) and that recruitment to the membrane is
required for Csk function (6, 10). In this context, we and others
have recently identified a membrane phosphoprotein that can
tightly bind to the SH2 domain of Csk (Cbp or PAG) (11, 12).
Upon phosphorylation, Cbp/PAG can recruit Csk to a mem-
brane microdomain, so-called lipid Rafts, to terminate SFK
signaling. More recently, we found that the binding to the
phosphorylated Cbp/PAG could directly activate Csk (13). Thus
it is likely that Cbp/PAG plays an important role in Csk regu-
lation. On the other hand, other proteins that could function-
ally bind to the SH2 domain of Csk, such as Paxillin and FAK,
have been identified previously (7). These findings suggest that
Csk is regulated through its SH2 domain in vivo, although the
molecular basis of this regulation remains thoroughly un-
known. To address this issue, we here elucidated the entire
structure of Csk by crystallographic analysis.
EXPERIMENTAL PROCEDURES
Expression and Purification of Csk—The full-length (amino acids
1–450) rat Csk was expressed using baculovirus vector in insect cells
and purified essentially by the same methods as described previously
(13), except that -octyl-D-glucoside was added (instead of Nonidet
P-40) to the buffer during chromatography processes and that the final
gel filtration chromatography was performed in a buffer consisting of
100 mM Tris-HCl (pH 8.5), 150 mM NaCl, 5 mM -mercaptoethanol, 1
mM EDTA, 5% glycerol, and 0.02% -octyl-D-glucoside. Size estimation
was carried out on a Superdex200 HR10/30 column equilibrated with
phosphate-buffered saline. Sedimentation equilibrium was performed
by ultracentrifugation at 17,000 rpm for 22 h. Concentration distribu-
tions were measured using the Rayleigh interference optics.
Crystal Structure Analysis—The purified Csk was concentrated to
12 mg/ml, mixed with 50 mM Hepes-NaOH (pH 7.4) containing 1.90–
1.95 M ammonium sulfate, and crystallized in a sitting drop by vapor
diffusion at 288 K for 1–2 months. All data were collected at the
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cryogenic temperature (around 100 K) using 25% (v/v) ethylene glycol
as a cryoprotectant. The native1, native2, and Hg data were collected on
the PX210 (Oxford) at BL44XU, Quantum4 (adsc) at BL40B2, and on
the marCCD (Mar research) at BL41XU in SPring-8, respectively. The
diffraction images were reduced and scaled with Mosflm (ccp4 (14)) and
Scala (ccp4) in native1 and Denzo/Scalepack (15) in native2 and Hg
data sets. The intensities were converted to the structure factor ampli-
tudes with TRUNCATE (ccp4). Subsequent phasing calculations were
performed using native2 and Hg data. The six Hg positions were first
located using SHELXS-97 (16), followed by the minor site specification,
heavy atom parameter refinement, and the SIRAS phase calculation
with SHARP (17). The density modification with SOLOMON (ccp4)
permitted us clear interpretation of the electron density map. The
atomic model was built using O (18) and refined with the native1 data
set using CNS (19). Of the 2,298 non-glycine and non-proline residues,
83.0% fell into the most favored regions, 16.1% into the additional
allowed regions, 0.9% into the generously allowed regions, and no
residue into the disallowed regions of Ramachandran plot as defined in
PROCHECK. Coordinates have been deposited with the Protein Data
Bank under accession codes 1K9A.
RESULTS AND DISCUSSION
Overview of Csk Structure—The full-length rat Csk was pro-
duced using a baculovirus vector in insect cells and purified
through sequential column chromatography. Although Csk
from the brain tissue (0.01 mg/ml) behaved as a monomer (50
kDa) on gel filtration chromatography (20), the highly concen-
trated Csk from insect cells (1 mg/ml) was eluted with an
apparent molecular size around 100 kDa (data not shown).
Sedimentation equilibrium analysis also revealed that Csk is
present as a dimer at concentrations around 1 mg/ml (data not
shown). These findings demonstrate that Csk tends to dimerize
at high protein concentrations in vitro. The crystal structure of
Csk was solved by the heavy atom single isomorphous replace-
ment method. Crystallographic data and refinement statistics
are shown in Table I. An interesting feature of Csk crystal is
that it consists of six molecules divided into three pairs of
putative dimers per asymmetric unit. This is probably because
of oligomerization of Csk dimers during crystallization pro-
cesses. The dimers are made with loose interactions through
the backside of the kinase domains and the SH3 domains. Two
of the six molecules, in distinct dimers, make further contact
with each other and appear to have some distortions in their
structures as described later. In every molecule, however, the
three functional domains, SH2, SH3, and kinase, are arranged
in a similar manner with the SH2 and SH3 domains diametri-
cally opposite on the top of the N-lobe of the kinase domain
(Fig. 1, A and C). Although the position of the SH3 domain
resembles the position of the SH3 domain of inactive forms of
SFKs, the position of the SH2 domain is entirely different (3).
In addition, there is no direct contact between the SH2 and
SH3 domains of Csk.
Arrangements of the SH2 and SH3 Domains—The SH3 do-
mains fold canonically with two anti-parallel sheets of five
-strands sandwiched into a compact structure. There are vir-
tually no differences from the structure of an isolated Csk-SH3
domain (21) except that the N-terminal region is disordered in
the isolated SH3 domain (Fig. 1A). The peptide-binding pocket
of the SH3 domain is oriented outward (Fig. 1C) enabling the
intermolecular interaction, and the interactions between the
SH3 and SH2-kinase linker observed in inactive SFK struc-
tures are absent. The SH2 domains are also canonical, consist-
ing of a central -sheet flanked by two -helices as in c-Src (Fig.
1A), although an insertion is present in the loop region of the
c-Src SH2 domain. However, a significant difference can be
observed in the orientations of the SH2 domains when all six
Csk molecules are superimposed (Fig. 1B). In four Csk mole-
FIG. 1. A, ribbon diagram of a representative Csk structure (active
molecule) in the crystal. Domain structures are distinctively colored:
SH2 in blue, SH3 in purple, N-lobe in dark green, C-lobe in light green,
and the activation segment in red. B, superimposed model of the six Csk
molecules in an asymmetric unit. Active molecules are shown in green
and inactive molecules are in blue. C, schematic models of the struc-
tures of Csk (left) and c-Src (right). Peptide binding pockets of the SH2
and SH3 domains are shown by hollows. The rotated SH2 domain of the
inactive molecule is colored pink. Phosphate on the tail tyrosine (Tyr-
527) of c-Src is colored red.
TABLE I
Summery of crystallographic data and refinement statistics
Native1 Native2 CH3HgBr
Space group P212121
Cell parameters
a (Å) 115.0 115.0 115.1
b (Å) 162.6 162.6 162.9
c (Å) 232.4 232.4 232.5
Wavelength (Å) 0.900 1.000 1.007
Resolution rangea (Å) 73–2.5 (2.64–2.50) 30–2.6 (2.69–2.60) 49–2.9 (3.0–2.9)
Number of unique reflectionsa 150,489 (17,029) 136,322 (13,573) 93,131 (9,172)
Completenessa 98.2 (98.2) 99.4 (99.9) 99.9 (98.8)
Multiplicitya 5.0 (4.5) 5.2 (4.9) 5.9 (5.1)
I/a 6.9 (1.7) 8.8 12.1
Rsym
a (%) 7.3 (39.8) 5.9 (39.0) 6.9 (36.2)
Rcryst/Rfree (%) 24.6/28.8
Root mean square deviation
Bond lengths (Å) 0.007
Bond angles (°) 1.427
a Values in parentheses are for the last resolution shell.
Structure of Csk14352
 at O
SA
K
A
 U
N
IV
ERSITY
 on N
ovem
ber 10, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
cules, the ligand binding surfaces face to the left in Fig. 1B,
whereas those of the other two are rotated upward 60° (Fig.
1B). This disorientation may reflect an unusual flexibility of
the SH3-SH2 linker and SH2-kinase linker, which form a hinge
about which the SH2 domain pivots. These two linkers make
extensive hydrophobic contacts with the N-lobe of the kinase
domain (Fig. 1A and Fig. 3). In the SH2-kinase linker, there is
an -helix, which is designated as BC, that is absent from
SFKs (Fig. 1A). All the hydrophobic residues involved in en-
gaging the SH2 and kinase domains are highly conserved
among Csks derived from various species, suggesting that
docking of the SH2 linkers into the kinase domain is important
for regulation.
Active Conformation of the Kinase Domain—The kinase do-
mains of the four Csk molecules whose SH2 domains face to the
left in Fig. 1B can be readily superimposed on the kinase
domain of an active SFK, Lck (22). The positions of residues
crucial for catalytic activity (Asp-314, Asn-319, and Asp-332)
and the critical ion bridge that orients the -phosphate of ATP
(Glu-236 in C and Lys-222 in 3) are consistent with those of
Lck (Fig. 2, A and B). All these features suggest that the four
molecules are most likely to be enzymatically active. The active
site similarity with Lck is rather remarkable considering that
Csk differs from SFKs in its activation loop (Fig. 2, red). The
activation loop of Csk (331–348) is four residues shorter than
and diverged from that of Lck, and, critically, it lacks a phos-
phorylated tyrosine residue (Fig. 2E). In addition, Csk residues
are either substantially displaced as compared with their coun-
terparts in Lck (338–342, 346–349) or disordered (343–345). In
SFKs, autophosphorylation of the activation loop tyrosine is
regulatory and essential for full catalytic activity and for trans-
forming potential (23, 24). In Lck, this phosphotyrosine
(Tyr-394) is essential to coordinate Arg-363 and Arg-387 and
thus stabilize the active structure. In Csk, however, the side
chain of Lys-337, which corresponds to Arg-387 in Lck, has no
apparent coordinations to a specific partner, yet the main chain
lies within 1.5 Å of Lck Arg-337 when the C-lobes are
superimposed.
The similarity in active sites despite the absence of phos-
phate in the activation loop suggests that another mechanism
maintains the active conformation of Csk. Previously it has
been reported that deletion of sequences preceding the kinase
domain significantly reduces Csk activity (7, 8, 25, 26), and a
role of the SH3-SH2 linker in Csk activation has been sug-
gested (8). In a structure of the isolated kinase domain bound to
staurosporine, the helix C is kinked and flexible, destroying
the critical salt bridge between Lys-222 and Glu-236 (Fig. 2D)
(27). In the case of Lck, however, an isolated kinase domain
retains full activity (28). As already mentioned, in Csk there
are tight interactions between the two linkers and the N-lobe of
the kinase domain. Notably, the helix C, which positions
Glu-236, is oriented by extensive contacts with the linkers (Fig.
3). This resembles the case of CDK2 that is partially activated
through binding to cyclin A (29). The binding of cyclin A to the
helix C (containing PSTAIRE motif) of CDK2 induces a dra-
matic change in the orientation of the helix C so that the
catalytic residues are appropriately coordinated for the catal-
ysis. Therefore, instead of the activating phosphotyrosine, Csk
may require the interaction between the kinase domain and
the linkers to stabilize the active conformation.
FIG. 2. Arrangements of the catalytically important residues in Lck
(A), active Csk and a simulated annealing omit map at 1.5  in the
vicinity of the salt bridge between Lys-222 and Glu-236 (B), inactive
Csk (C), and the isolated kinase domain of Csk (27) (D) are shown. The
salt bridge between Lys-222 and Glu-236 is indicated by dotted line in
A and B. E, sequence alignment of the activation loops of Csk, Lck, c-Src
(Src) and insulin receptor kinase (IRK). Autophosphorylated tyrosines
are colored red.
FIG. 3. Stereo representations of the interaction between the
SH3-SH2 linker, SH2-kinase linker, and the kinase domain in
active Csk (A) and inactive Csk (B). The interaction between the
D-E loop and 3-C loop cannot been seen in the inactive Csk.
FIG. 4. Cross-correlation matrices for the four active Csk mol-
ecules. The SH2 domain (82–172), 1-2 and 3-C loop (204–207),
and 3-C loop and C (225–243) are emphasized by the bold lines. The
C-lobes of four molecules were superimposed prior to the calculation.
The correlation coefficients cij, which are plotted according to the scale
indicated on the top, are defined as cij  (rirj)/((ri2)1/2(rj2)1/2),
where ri is the deviation of the backbone carbon position from the
average position of the “i”th residue.
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Inactive Conformation of the Kinase Domain—In contrast
with the active molecules, the two Csk molecules with rotated
SH2 domains appear to be inactive. These molecules are sub-
stantially different from the active molecules in the backbone
carbon positions of the N-lobe of the kinase domain (Fig. 1B).
Importantly, the critical ion pair (between Glu-236 and Lys-
222) is absent (Fig. 2C) although the conformation of the cat-
alytic domain is apparently different from that of the isolated
kinase domain bound to staurosporine (27). Furthermore, there
is a major difference between the active and inactive molecules
in the SH2-kinase interface (Fig. 3); the interactions between
the D-E loop of the SH2 domain and 3-C loop in the N-lobe
of kinase domain are absent in the inactive molecules. These
indicate that rotation of the SH2 domain could affect the con-
formation of the N-lobe of the kinase domain, implicating the
functional relationship between the SH2 domain and the ki-
nase domain.
Regulatory Feature of Csk—To address the above issue, we
calculated cross-correlation matrices for the deviations of the
backbone carbon atoms of the molecules in the crystal. The
cross-correlation matrix was recently found to be useful to
assess interdomain interactions in molecular dynamics studies
(30). Fortunately, our crystal contained multiple copies of Csk
molecules in an asymmetric unit, and we used four crystallo-
graphically independent copies instead of conformational snap-
shots in the molecular dynamics study. The C-lobes of the
kinase domains were first superimposed by the program
LSQKAB (14), and then we generated a set of averaged posi-
tions of the  carbon. The correlation between two atoms can be
defined using the deviations from their respective average po-
sitions. It is obvious that the correlation value for two atoms in
the same domain shows an absolute value close to 1 as the
domain moves en bloc. If two residues move independently, the
correlation will be near 0. It is usually observed that the cor-
relation between two atoms in the “superimposed” region is
flattened to 0. As shown in Fig. 4, for four active-state mole-
cules, clusters of positive correlations between two atoms lie in
the regions indicating correlations between the SH2 domain
and 1-2 and 3-C regions of the kinase domain. This indi-
cates that these segments deviate en bloc in the crystal, repre-
senting a functional coupling between the SH2 and the kinase
domain.
The structure of Csk presented here highlights the func-
tional interactions of the catalytic domain with the SH2 do-
main and its linkers and suggests a novel activation mecha-
nism that is distinct from the phosphorylation-dependent
regulation of SFKs. The presence of an inactive conformation of
Csk, which is probably produced by the unusual flexibility of
the hinge region of the SH2 domain, also suggests that there
may be a dynamic equilibrium between active and inactive
Csk. It is known that a strong ligand of the SH2 domain, the
phosphorylated Cbp/PAG, could elicit potentially full activity of
Csk (13). Therefore, it is probable that binding of Cbp/PAG
ligand to the SH2 domain could fix the active state to make the
kinase constitutively active. It is also possible that the confor-
mation change induced by the SH2 ligand could affect the
region responsible for the substrate recognition. To verify these
hypotheses, the structural details of Csk association with Cbp/
PAG are now under investigation.
Among the many types of cytoplasmic protein tyrosine ki-
nases, including the Fes, Abl, Syk, Tec, and Csk families, the
SFKs are unusual in that they are negatively regulated by
phosphorylation of the C-terminal regulatory site. The SH2
domain of the SFK serves as an acceptor for the phosphorylated
regulatory tyrosine. All the aforementioned cytoplasmic tyro-
sine kinases also possess an SH2 domain adjacent to the cata-
lytic domain but have no C-terminal phosphotyrosine. Al-
though the actual roles of SH2 domains in these enzymes
remain to be studied at the molecular level, the structures of
Csk presented here could be representative of cytoplasmic ty-
rosine kinases other than SFKs.
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